Rescheduling of release of annual results and renewal of cautionary announcement Ascendis Health Limited (Registration number 2008/005856/06) (Incorporated in the Republic of South Africa) Share code: ASC ISIN: ZAE000185005 (“Ascendis Health” or “the Group”) Rescheduling of release of annual results and renewal of cautionary announcement RESCHEDULING OF RELEASE OF ANNUAL RESULTS Shareholders are advised that owing to complexities relating to the accounting treatment of discontinued operations and the implementation of new accounting standards, the Group’s annual results for the year ended 30 June 2019 will now be released on or before 31 October 2019. The board and management apologise for the inconvenience caused by the further delay in the release of the annual results. Details on the timing of the release of the annual results on SENS and the investor presentation will be communicated later in October. RENEWAL OF CAUTIONARY ANNOUNCEMENT Shareholders are referred to the previous cautionary announcement and subsequent renewals, the latest being released on SENS on 3 September 2019, relating to the proposed disposal of the Remedica business unit in Cyprus. Shareholders are advised to continue to exercise caution when dealing in Ascendis Health’s securities until a further announcement is made. 2 October 2019 Bryanston Sponsor Questco Corporate Advisory (Proprietary) Limited Date: 02/10/2019 01:52:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.